drugset / Trial / NCT00172419

The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.

NCT00172419

NaSingle-groupOpen-labelTreatment

Summary

Inflammation is important in the both pathogenesis and outcome of atherosclerosis. Plaques containing numerous inflammatory cells, particular macrophages, have a high risk of rupture.We hypothesize that statin-induced plaque regression could be monitored clinically by use of FDG PET/CT approach, and can be detected noninvasively earlier than previously reported.

Timeline

Start
2007-03
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg

Indications